This new study in the journal of Pediatrics indicated that there was no increased risk of Autism Spectrum Disorder associated with receipt of thimerosal-containing vaccines. The study also found no increased risk for any of the subtypes of Autism Spectrum Disorder, including ASD with regression. In addition, it found no increased risk of Autism Spectrum Disorder associated with prenatal exposure to thimerosal. No significant differences in exposure effects were found between boys and girls for any of the ASD outcomes; there was no evidence that higher prenatal exposure exacerbated the effects of post-natal exposure; and there was no evidence that concurrent ethylmercury exposure was associated with ASD. In addition, there was no substantive difference in the association between thimerosal exposure and risk for ASD among children with an older sibling with autism and those without an older sibling with autism.